Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Costs and benefits of diagnosing familial breast cancer.
Heimdal K, Maehle L, Møller P. Heimdal K, et al. Among authors: maehle l. Dis Markers. 1999 Oct;15(1-3):167-73. doi: 10.1155/1999/751892. Dis Markers. 1999. PMID: 10595273 Free PMC article.
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.
Evans DG, Gaarenstroom KN, Stirling D, Shenton A, Maehle L, Dørum A, Steel M, Lalloo F, Apold J, Porteous ME, Vasen HF, van Asperen CJ, Moller P. Evans DG, et al. Among authors: maehle l. J Med Genet. 2009 Sep;46(9):593-7. doi: 10.1136/jmg.2008.058248. Epub 2008 Apr 15. J Med Genet. 2009. PMID: 18413372
Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations.
Hagen AI, Bofin AM, Ytterhus B, Maehle LO, Kjellevold KH, Myhre HO, Møller P, Lønning PE. Hagen AI, et al. Among authors: maehle lo. Acta Oncol. 2007;46(2):199-203. doi: 10.1080/02841860600949552. Acta Oncol. 2007. PMID: 17453369
A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing.
Dørum A, Møller P, Kamsteeg EJ, Scheffer H, Burton M, Heimdal KR, Maehle LO, Hovig E, Tropé CG, van der Hout AH, van der Meulen MA, Buys CH, te Meerman GJ. Dørum A, et al. Among authors: maehle lo. Eur J Cancer. 1997 Dec;33(14):2390-2. doi: 10.1016/s0959-8049(97)00328-6. Eur J Cancer. 1997. PMID: 9616287
Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.
Levin T, Mæhle L. Levin T, et al. Among authors: maehle l. Fam Cancer. 2017 Apr;16(2):257-265. doi: 10.1007/s10689-016-9939-8. Fam Cancer. 2017. PMID: 27804060 Free PMC article.
Fanconi anaemia, BRCA2 and familial considerations - follow up on a previous case report.
Bodd TL, Van Ghelue M, Eiklid K, Ruud E, Møller P, Mæhle L. Bodd TL, et al. Among authors: maehle l. Acta Paediatr. 2010 Nov;99(11):1741-3. doi: 10.1111/j.1651-2227.2010.01929.x. Acta Paediatr. 2010. PMID: 20608899 No abstract available.
No sib pair concordance for breast or ovarian cancer in BRCA1 mutation carriers.
Møller P, Maehle L, Clark N, Apold J. Møller P, et al. Among authors: maehle l. Hered Cancer Clin Pract. 2007 Jun 15;5(2):67-71. doi: 10.1186/1897-4287-5-2-67. Hered Cancer Clin Pract. 2007. PMID: 19725986 Free PMC article.
[Hereditary breast cancer].
Møller P, Maehle L, Apold J. Møller P, et al. Among authors: maehle l. Tidsskr Nor Laegeforen. 2005 Nov 17;125(22):3136-8. Tidsskr Nor Laegeforen. 2005. PMID: 16299574 Norwegian.
Quality of life and its relation to cancer-related stress in women of families with hereditary cancer without demonstrated mutation.
Geirdal AØ, Maehle L, Heimdal K, Stormorken A, Møller P, Dahl AA. Geirdal AØ, et al. Among authors: maehle l. Qual Life Res. 2006 Apr;15(3):461-70. doi: 10.1007/s11136-005-3008-3. Qual Life Res. 2006. PMID: 16547785
Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.
Sjursen W, Haukanes BI, Grindedal EM, Aarset H, Stormorken A, Engebretsen LF, Jonsrud C, Bjørnevoll I, Andresen PA, Ariansen S, Lavik LA, Gilde B, Bowitz-Lothe IM, Maehle L, Møller P. Sjursen W, et al. Among authors: maehle l. J Med Genet. 2010 Sep;47(9):579-85. doi: 10.1136/jmg.2010.077677. Epub 2010 Jun 28. J Med Genet. 2010. PMID: 20587412 Free PMC article.
101 results
Jump to page